Welcome to our dedicated page for Cerence SEC filings (Ticker: CRNC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cerence Inc. SEC filings document formal disclosures for a public software company focused on conversational AI-powered user experiences. Recent 8-K filings include earnings releases and investor presentations with GAAP and non-GAAP financial measures, revenue and cash-flow disclosures, and commentary on software licensing, connected services and customer-program activity.
The filings also record shareholder meeting results, board elections, advisory compensation votes, auditor ratification, restructuring-related charges, executive compensation arrangements, and material intellectual-property matters, including patent litigation resolution and license agreements. These records frame Cerence's governance, operating costs, capital allocation and technology-rights disclosures.
Cerence Inc. insider sale reported. Christian Mentz, EVP and Chief Revenue Officer, sold 4,000 shares of Cerence common stock on 08/14/2025 at a reported price of $12.7358 per share. After the sale, Mr. Mentz beneficially owned 138,747 shares, held directly. The Form 4 was signed by an attorney-in-fact, Jennifer Salinas, on 08/18/2025 and states the transaction represents shares sold by the reporting person.
Cerence Inc. (CRNC) filed a Form 144 notice reporting a proposed sale of 4,000 shares of common stock, with an aggregate market value of $50,943.20. The shares are part of an issuance recorded as restricted stock acquired from the issuer on 10/01/2024 and were paid in full on that date. The filing names Morgan Stanley Smith Barney LLC as the broker and lists an approximate sale date of 08/14/2025 on the NASDAQ. Total shares outstanding are reported as 43,319,651. The filer affirms they do not possess undisclosed material adverse information about the issuer.